StockData
Opus Genetics, Inc. logo

Opus Genetics, Inc. (IRD) stock

IRDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$3.92−0.13 (-3.21%)

Close on Nov 18, 2026Market cap $326.13MP/E –Yield –

Opus Genetics gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

For fiscal 2009 it was -$100.00K.

Annual gross profit

PeriodPeriod endValueChange
FY2009Dec 31, 2009-$100.00K–

More Opus Genetics figures

See a number that looks wrong?